SCHEMBL23383173

SCHEMBL23383173

COC(Oc1ccc(C(=O)OC2(C(F)(F)C(=O)O)CCCCC2)cc1)C(C)C

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ SLC6A4 P31645 5/20 0.32
▸ SLC6A3 Q01959 5/20 0.32
▸ SLC6A2 P23975 3/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ THRB P10828 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382835 0.79 ADORA3 (0.43) KMT2ASMN1; SMN2ADORA3MEN1SLC6A4
SCHEMBL23383171 0.79 KDM4E (0.37) KMT2ASMN1; SMN2ADORA3MEN1KDM4E
SCHEMBL23382837 0.78 ADORA3 (0.35) KMT2ASMN1; SMN2NPSR1ADORA3MEN1
SCHEMBL23382836 0.78 ADORA3 (0.35) KMT2ASMN1; SMN2NPSR1ADORA3MEN1
SCHEMBL23382833 0.78 ADORA3 (0.38) KMT2ASMN1; SMN2NPSR1ADORA3MEN1
SCHEMBL23383172 0.78 CYP19A1 (0.37) KMT2ASMN1; SMN2NPSR1ADORA3MEN1
SCHEMBL23383170 0.77 CA12 (0.38) ADORA3ALDH1A1
SCHEMBL23383169 0.76 SMN1; SMN2 (0.34) KMT2ASMN1; SMN2NPSR1ADORA3MEN1
SCHEMBL23382838 0.76 ELANE (0.49) KMT2AADORA3MEN1SLC6A4SLC6A3
SCHEMBL23382834 0.76 ADORA3 (0.48) SMN1; SMN2ADORA3SLC6A4SLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 KMT2A 2745/4885SMN1; SMN2 3745/4885NPSR1 3275/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 KMT2A 2745/4885SMN1; SMN2 3745/4885NPSR1 3275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback